Abstract

Drug resistance among parasitic nematodes has resulted in an urgent need for the development of new therapies. However, the high re-discovery rate of anti-nematode compounds from terrestrial environments necessitates a new repository for future drug research. Marine epiphytes are hypothesised to produce nematicidal compounds as a defence against bacterivorous predators, thus representing a promising yet underexplored source for anti-nematode drug discovery. The marine epiphytic bacterium Pseudoalteromonas tunicata is known to produce several bioactive compounds. Screening heterologously expressed genomic libraries of P. tunicata against the nematode Caenorhabditis elegans, identified as an E. coli clone (HG8), shows fast-killing activity. Here we show that clone HG8 produces a novel nematode-killing protein-1 (Nkp-1) harbouring a predicted carbohydrate-binding domain with weak homology to known bacterial pore-forming toxins. We found bacteria expressing Nkp-1 were able to colonise the C. elegans intestine, with exposure to both live bacteria and protein extracts resulting in physical damage and necrosis, leading to nematode death within 24 h of exposure. Furthermore, this study revealed C. elegans dar (deformed anal region) and internal hatching may act as a nematode defence strategy against Nkp-1 toxicity. The characterisation of this novel protein and putative mode of action not only contributes to the development of novel anti-nematode applications in the future but reaffirms the potential of marine epiphytic bacteria as a new source of novel biomolecules.

Highlights

  • Diseases resulting from parasitic helminth infections are a global concern, especially for resource-limited countries with poor hygiene and an inadequate clean water supply [1,2]

  • This study has identified the previously uncharacterised protein nematode-killing protein-1 (Nkp-1) as the causative agent for the nematode fast killing activity of the marine bacterium P. tunicata

  • Nkp1 does not appear to have any enzymatic activity; rather, based on the modelling of a carbohydrate-binding domain, Nkp-1 is hypothesised to act as a novel pore-forming toxin (PFT)

Read more

Summary

Introduction

Diseases resulting from parasitic helminth (nematode) infections are a global concern, especially for resource-limited countries with poor hygiene and an inadequate clean water supply [1,2]. Approximately 1.5 billion people suffer from parasitic helminth infections, with the majority of cases occurring in East Asia, sub-Saharan Africa, America and China [3]. Parasitic nematode infections are associated with malnutrition, anaemia, growth retardation, diminishing fitness, reduced cognition and result in numerous fatalities per year [2,4]. In addition to human illness, parasitic nematodes can infect agricultural crops and aquaculture products, reducing yield and threatening food security [5,6]. For the past 40 years, strategies to control parasitic nematodes have almost exclusively relied on intensive chemotherapy to relieve symptoms and diminish transmission. Overuse and frequent parasite exposure to single broad-spectrum therapeutic drugs can increase the prevalence of anthelmintic resistance among harmful parasites [7,8,9] and finding new anthelmintic compounds has become a matter of global urgency

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call